Appointment booking for Dr. Matthew Guillory, MD is currently not available.Dr. Matthew Guillory, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Matthew Guillory, MD (he/him) is a Internist in Baton Rouge, LA with over 14 years of experience. What is your opinion of Dr. Matthew Guillory, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 14 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Matthew Guillory, MD has received over $2,908 which includes payments from the following companies:
$784.18 from Otsuka America Pharmaceutical, Inc.
$493.38 from Janssen Pharmaceuticals, Inc
$261.55 from sanofi-aventis U.S. LLC
$245.78 from Boehringer Ingelheim Pharmaceuticals, Inc.
$233.82 from Relypsa, Inc.
$219.43 from Pfizer Inc.
$144.10 from The Medicines Company
$133.36 from GlaxoSmithKline, LLC.
$92.75 from E.R. Squibb & Sons, L.L.C.
$72.84 from Allergan Inc.
$72.44 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$35.91 from Merck Sharp & Dohme Corporation
$35.72 from Astellas Pharma US Inc
$32.77 from CSL Behring
$15.15 from Novo Nordisk Inc
$13.19 from AstraZeneca Pharmaceuticals LP
$11.49 from Arbor Pharmaceuticals, Inc.
$10.70 from Melinta Therapeutics, Inc.
Payments received by Dr. Matthew Guillory, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!